Patently absurd

2 October 2017 By Reynolds Holding

The $70 bln drugmaker’s fishy deal with Native Americans may impede a U.S. tribunal from cracking down on such rights. Weak rules in the forum also face review in the new Supreme Court term. With luck, the pushback will lead to better remedies for flawed intellectual property.

This content is for Subscribers only

To access full Breakingviews.com content you must be a subscriber. Please use the following link to request a trial.

 

Email a friend

Please complete the form below.

Required fields *

*
*
*

(Separate multiple email addresses with commas)